BibTex RIS Cite

Epidemiologic and survival characteristics of patients with colorectal cancer in Ege University medical faculty database

Year 2019, , 68 - 77, 31.12.2019
https://doi.org/10.19161/etd.668311

Abstract

Aim: The aim of this study was to determine epidemiological and overall survival (OS) characteristics
of colorectal cancer (CRC) patients.
Materials and Methods: Data of Ege University Cancer Control and Research Center between 1992-
2017 were screened retrospectively. Data recorded in CANREG program were grouped and analyzed
in WHO and SEER systems. Chi-square test, General Linear Model (GLM) and Kaplan-Meier survival
analysis were used for statistical analysis.
Results: Number of CRC cases were 7285 (6.2%) among 117139 cancer cases. CRC ranked 7th
among all the cancer types. Of the CRC patients, 4330 (59%) were male. The most common
localization was rectum (38.4%). CRC increases with age. A significant increase was found at the age
of 60 years and older (p=0.022) among both genders, but the difference between genders was not
significant (p=0.299). Linear increase over the years was significant in total (GLM: F=12,349;
p<0.0001). Adenocarcinoma (86%) was the most common histologic type, 54.2% of patients were
diagnosed at locally advanced stage. The 5-year OS rate was 66.4% in locally advanced cancer and
15.8% in case of distant metastasis (p<0.0001). Median survival was 69 months, 5 and 10-year OS
rates were 53% and 40% respectively. Ten-year OS was significantly higher in women. Five and 10-
year OS rates were significantly lower in ≥70-year-old age group, and subsequently in the 20-29 years
age group if ≥70-year-old age group was not taken into account (p<0.0001).
Conclusion: There is an increase in CRC over the years, and generally the patients were diagnosed
in locally advanced stages. The 5-year OS rate was 54.5% in the 60-69 age group which accounts for
the most common age group, Ten-year OS rate was 43.3% in women which was higher than in men.
Histology and stage were the most important prognostic parameters in prognosis.

References

  • Bray, F, Ferlay J, Soerjomataram I, Siegel RL., Torre LA and Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 2018;68:394-424.
  • Magalhaes B, Peleteiro B, Lunet N. Dietary patterns and colorectal cancer: systematic review and meta‐ analysis. Eur J Cancer Prev. 2012;21:15‐23.
  • Bates B, Cox L, Nicholson S, et al. National Diet and Nutrition Survey: Results from Years 5 and 6 (combined) of the Rolling Programme (2012/2013–2013/2014) London: Public Health England; 2016.
  • Bosman, F.T. WHO Classification of Tumours of the Digestive System. World Health Organization Classification of Tumours, 4th Edition, International Agency for Research on Cancer, Lyon.
  • Sağlık Bakanlığı, Kanserle Savaş Dairesi Başkanlığı, Türkiye 2010 Kanser İstatistikleri, www.kanser.gov.tr.
  • Farinetti A, Zurlo V, Manenti A, Coppi F, Mattioli AV. Mediterranean diet and colorectal cancer: A systematic review. Nutrition. 2017 Nov - Dec;43-44:83-8.
  • Jones P, Cade JE, Evans CEL, Hancock N, Greenwood DC. The Mediterranean diet and risk of colorectal cancer in the UK Women's Cohort Study. Int J Epidemiol. 2017 Dec 1;46(6):1786-96.
  • Murphy G, Devesa SS, Cross AJ, Inskip PD, McGlynn KA, Cook MB. Sex disparities in colorectal cancer incidence by anatomic subsite, race and age. Int J Cancer. 2011;128(7): 1668-75.
  • White A, Ironmonger L, Steele RJC, Ormiston-Smith N, Crawford C, Seims A. A review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK. BMC Cancer. 2018;18(1):906.
  • EC. The State of Men’s Health in Europe Report (Extended report) Luxembourg: European Commission; 2011.
  • Wolf AM, Fontham ET, Church TR, et al. Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society. CA: A Cancer Journal for Clinicians, 2018;68:250-81.
  • American Cancer Society. Cancer Facts & Figures 2019. Atlanta, Ga: American Cancer Society; 2019.
  • De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5 – a population-based study. LancetOncol 2014;15:23–34.
  • Yeole BB, Sunny L, Swaminathan R, Sankaranarayanan R, Parkin DM. Population-based survival from colorectal cancer in Mumbai, (Bombay) India. Eur J Cancer. 2001Jul; 37(11):1402-8.
  • Park YJ, Park KJ, Park JG, Lee KU, Choe KJ, Kim JP. Prognostic factors in 2230 Korean colorectal cancer patients: analysis of consecutively operated cases. World J Surg. 1999 Jul; 23(7):721-6.
  • Arnold M, Sierra MS, Laversanne M, et al. Global patterns and trends in colorectal cancer incidence and mortality Gut 2017;66:683-91.

Ege Üniversitesi Tıp Fakültesi veri tabanındaki kolorektal kanserli olguların epidemiyolojik ve genel sağ kalım özellikleri

Year 2019, , 68 - 77, 31.12.2019
https://doi.org/10.19161/etd.668311

Abstract

Amaç: Kolorektal kanser (KRK) epidemiyolojisi ve genel sağ kalım (GSK) özelliklerinin
araştırılmasıdır.
Gereç ve Yöntem: Ege Üniversitesi Kanserle Savaş Uygulama ve Araştırma Merkezine (EÜKAM)
1992-2017 yıllarında kayıtlı Ege Üniversitesi Tıp Fakültesi kanser verileri retrospektif olarak
taranmıştır. CANREG özel bilgisayar programına kayıtlı veriler, WHO ve SEER sistemlerinde
gruplanarak analizler yapılmıştır. İstatistiksel analizlerde Ki-kare, General Linear Model (GLM),
Kaplan-Meier sağ kalım analizleri kullanılmıştır. Yerel etik kurul onayı alınmıştır.
Bulgular: Toplam 117.139 kanser olgusunun 7.285’i (%6,2) KRK’dir. KRK sıklığı, tüm olgular içinde
yedinci sırada saptanmıştır. Olguların 4.330’u (%59) erkektir. Rektum yerleşimi, %38,4 olguda
saptanmış olup, en sık lokalizasyondur. KRK yaşla artmaktadır; 60 yaş ve üzerinde her iki cinsiyette
de anlamlı artış saptanmıştır (p=0,022); cinsiyetler arası fark anlamlı değildir (p=0,299). KRK’de yıllara
göre doğrusal artış toplamda anlamlıdır (GLM: F=12,349; p<0,0001). Olguların %86’sı
adenokarsinomdur, %54,2’si lokal ileri evrede tanı almıştır. Lokal ileri evrede beş yıllık GSK %66,4
iken, uzak metastaz varlığında %15,8’e düşmektedir (p<0,0001). Medyan sağ kalım 69 ay, beş ve 10
yıllık GSK oranları sırasıyla %53 ve %40’tır. On yıllık GSK oranı kadınlarda istatistiksel olarak anlamlı
yüksektir. Yetmiş yaş ve üstü, beş ve 10 yıllık GSK oranları istatistiksel olarak anlamlı düşüktür, 20-29
yaş olgularda GSK, 70 yaş ve üstü dikkate alınmazsa anlamlı düşük bulunmuştur (p<0,0001).
Sonuç: Hastanemizde yıllara göre KRK’de artış vardır, tanı genellikle lokal ileri evrede konulmuştur.
En sık görülme yaşı olan 60-69 yaş grubunda beş yıllık GSK %54,5’dir. On yıllık GSK kadınlarda
%43,3 olup erkeklerden daha yüksektir. Prognozda histoloji ve evre en belirleyici parametrelerdir.

References

  • Bray, F, Ferlay J, Soerjomataram I, Siegel RL., Torre LA and Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 2018;68:394-424.
  • Magalhaes B, Peleteiro B, Lunet N. Dietary patterns and colorectal cancer: systematic review and meta‐ analysis. Eur J Cancer Prev. 2012;21:15‐23.
  • Bates B, Cox L, Nicholson S, et al. National Diet and Nutrition Survey: Results from Years 5 and 6 (combined) of the Rolling Programme (2012/2013–2013/2014) London: Public Health England; 2016.
  • Bosman, F.T. WHO Classification of Tumours of the Digestive System. World Health Organization Classification of Tumours, 4th Edition, International Agency for Research on Cancer, Lyon.
  • Sağlık Bakanlığı, Kanserle Savaş Dairesi Başkanlığı, Türkiye 2010 Kanser İstatistikleri, www.kanser.gov.tr.
  • Farinetti A, Zurlo V, Manenti A, Coppi F, Mattioli AV. Mediterranean diet and colorectal cancer: A systematic review. Nutrition. 2017 Nov - Dec;43-44:83-8.
  • Jones P, Cade JE, Evans CEL, Hancock N, Greenwood DC. The Mediterranean diet and risk of colorectal cancer in the UK Women's Cohort Study. Int J Epidemiol. 2017 Dec 1;46(6):1786-96.
  • Murphy G, Devesa SS, Cross AJ, Inskip PD, McGlynn KA, Cook MB. Sex disparities in colorectal cancer incidence by anatomic subsite, race and age. Int J Cancer. 2011;128(7): 1668-75.
  • White A, Ironmonger L, Steele RJC, Ormiston-Smith N, Crawford C, Seims A. A review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK. BMC Cancer. 2018;18(1):906.
  • EC. The State of Men’s Health in Europe Report (Extended report) Luxembourg: European Commission; 2011.
  • Wolf AM, Fontham ET, Church TR, et al. Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society. CA: A Cancer Journal for Clinicians, 2018;68:250-81.
  • American Cancer Society. Cancer Facts & Figures 2019. Atlanta, Ga: American Cancer Society; 2019.
  • De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5 – a population-based study. LancetOncol 2014;15:23–34.
  • Yeole BB, Sunny L, Swaminathan R, Sankaranarayanan R, Parkin DM. Population-based survival from colorectal cancer in Mumbai, (Bombay) India. Eur J Cancer. 2001Jul; 37(11):1402-8.
  • Park YJ, Park KJ, Park JG, Lee KU, Choe KJ, Kim JP. Prognostic factors in 2230 Korean colorectal cancer patients: analysis of consecutively operated cases. World J Surg. 1999 Jul; 23(7):721-6.
  • Arnold M, Sierra MS, Laversanne M, et al. Global patterns and trends in colorectal cancer incidence and mortality Gut 2017;66:683-91.
There are 16 citations in total.

Details

Primary Language Turkish
Subjects Health Care Administration
Journal Section Supplement
Authors

Nalan Gülşen Ünal 0000-0001-8870-2450

Gizem Coşgun 0000-0002-5745-0016

Mustafa Korkut 0000-0002-8077-0536

Ahmet Ömer Özütemiz 0000-0002-6960-4043

Başak Doğanavşargil 0000-0002-4738-4350

Burcu Çakar 0000-0003-3790-791X

Serdar Özkök 0000-0001-6546-5368

Deniz Yalman 0000-0002-4010-8353

Fatma Sert 0000-0001-6052-8614

Murat Sezak 0000-0002-0457-4832

Tayfun Yoldaş 0000-0002-1796-7854

Cemil Çalışkan 0000-0002-2652-3390

Zekeriya Erhan Akgün 0000-0003-0866-9529

Halit Osmanoğlu 0000-0001-8990-541X

Ayfer Haydaroğlu 0000-0001-5709-0981

Publication Date December 31, 2019
Submission Date February 15, 2019
Published in Issue Year 2019

Cite

Vancouver Ünal NG, Coşgun G, Korkut M, Özütemiz AÖ, Doğanavşargil B, Çakar B, Özkök S, Yalman D, Sert F, Sezak M, Yoldaş T, Çalışkan C, Akgün ZE, Osmanoğlu H, Haydaroğlu A. Ege Üniversitesi Tıp Fakültesi veri tabanındaki kolorektal kanserli olguların epidemiyolojik ve genel sağ kalım özellikleri. ETD. 2019:68-77.

1724617243172472652917240      26515    

 26507    26508 26517265142651826513

2652026519